Anti-CNOT6 antibody [EPR22022]
- RabMAb
- Recombinant
- KO Validated
- What is this?
3
(2 Reviews)
|
(5 Publications)
Rabbit Recombinant Monoclonal CNOT6 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CCR4, CCR4a, KIAA1194, CNOT6, CCR4-NOT transcription complex subunit 6, CCR4 carbon catabolite repression 4-like, Carbon catabolite repressor protein 4 homolog, Cytoplasmic deadenylase
- IP
Supplier Data
Immunoprecipitation - Anti-CNOT6 antibody [EPR22022] (AB221151)
CNOT6 was immunoprecipitated from 0.35 mg of HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab221151 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab221151 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab221151 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab221151 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-CNOT6 antibody [EPR22022] (ab221151)
Predicted band size: 36 kDa,63 kDa
Observed band size: 38 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-CNOT6 antibody [EPR22022] (AB221151)
CNOT6 was immunoprecipitated from 0.35 mg of Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate with ab221151 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab221151 at 1/500 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366), was used as secondary antibody at 1/1000 dilution.
Lane 1 : Jurkat whole cell lysate 10 μg (Input).
Lane 2 : ab221151 IP in Jurkat whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab221151 in Jurkat whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-CNOT6 antibody [EPR22022] (ab221151)
Predicted band size: 63 kDa
false
- WB
Supplier Data
Western blot - Anti-CNOT6 antibody [EPR22022] (AB221151)
Blocking/Dilution buffer : 5% NFDM/TBST.
The reactivity of the antibody with the target protein in the HeLa lysate was blocked by the inclusion of the peptide antigen.
All lanes:
Western blot - Anti-CNOT6 antibody [EPR22022] (ab221151) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HeLa whole cell lysate at 20 µg with CNOT6 Immunogen peptide
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 63 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CNOT6 antibody [EPR22022] (AB221151)
Western blot : Anti-CNOT6 antibody [EPR22022] ab221151 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 63 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in CNOT6 knockout MCF7 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-CNOT6 antibody [EPR22022] (ab221151) at 1/1000 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
Western blot - Human CNOT6 knockout MCF7 cell line (ab289386) at 20 µg
Lane 3:
HL-60 at 20 µg
Lane 4:
PC-3 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 63 kDa
Observed band size: 63 kDa,37 kDa
false
- WB
Lab
Western blot - Anti-CNOT6 antibody [EPR22022] (AB221151)
The expression profile is consistent with what has been described in the literature (PMID : 21741365).
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CNOT6 antibody [EPR22022] (ab221151) at 1/1000 dilution
Lane 1:
Human testis lysate at 20 µg
Lane 2:
Human ovary lysate at 20 µg
Lane 3:
Human heart lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 63 kDa
Observed band size: 60 kDa
false
Exposure time: 37s
- WB
Supplier Data
Western blot - Anti-CNOT6 antibody [EPR22022] (AB221151)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CNOT6 antibody [EPR22022] (ab221151) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
Human ovary cancer lysate at 20 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lane 4:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 63 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CNOT6 antibody [EPR22022] (AB221151)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CNOT6 antibody [EPR22022] (ab221151) at 1/1000 dilution
Lane 1:
His-tagged human CNOT6 recombinant protein(aa1-210) at 0.002 µg
Lane 2:
His-tagged human CNOT6L recombinant protein(aa1-210) at 0.002 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 63 kDa
false
Exposure time: 3s
Related conjugates and formulations (1)
-
Anti-CNOT6 antibody [EPR22022] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:5550 PubMed38956014
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 42:3564-3574 PubMed37853162
2023
Applications
Unspecified application
Species
Unspecified reactive species
Equine veterinary journal 56:178-192 PubMed37345447
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 83:2290-2302.e13 PubMed37295431
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 32:108120 PubMed32905781
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com